Announced Thu, 23 Jul · 16:11 IST
Thyrocare Q1 PAT up 39% to Rs 50 Cr; revenue rises 26% to Rs 226 Cr
Management Changes View source PDF
THYROCARE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+7.0%1-day move
₹544.95
prior close
₹560.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+5.4+3.1+1.3+4.2+7.0—————————
Up moveDown movePending
AI summary
Thyrocare Tech reported Q1 FY27 results. Standalone revenue from operations grew 26 percent YoY to Rs 225.66 Cr; PAT rose 39 percent to Rs 50.17 Cr (vs Rs 36.05 Cr). Basic EPS stood at Rs 3.15 versus Rs 2.27 restated. Consolidated revenue was Rs 240.02 Cr with PAT of Rs 51.33 Cr. Board also re-appointed Ernst and Young LLP as internal auditor for FY 2026-27.
Likely market impact
Strong Q1 with double-digit revenue and profit growth; auditor re-appointment is routine and shows continuity.